Skip to content

Effect of non-surgical periodontal therapy on galectin-3 and tumor necrosis factor–a levels in periodontitis patients with and without type 2 diabetes mellitus - A clinico-biochemical study.

Effect of non-surgical periodontal therapy on galectin-3 and tumor necrosis factor–a levels in gingival crevicular fluid of periodontitis patients with and without type 2 diabetes mellitus - A clinico-biochemical study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069285
Enrollment
100
Registered
2024-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Non surgical periodontal therapy ( Scaling ): NSPT is done using piezo ultra-sonic scaler on the healthy subjects, periodontitis patients with and without type 2 diabetes mellitus at t

Sponsors

Dr Divya Shonima
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Subjects of either gender, between the ages of 20 and 60 years. i. Presence of at least 20 natural teeth. ii. Healthy subjects with clinical parameters of bleeding on probing less than 10 % and probing depth less than or equal to 3 mm iii. Patients with diagnosis of generalised stage III grade B periodontitis with clinical parameters of probing depth more than or equal to 6 mm and clinical attachment loss more than or equal to 5 mm b) Subjects with type 2 diabetes mellitus ( HbA1c more than or equal to 6.4 % but less than 7 % )

Exclusion criteria

Exclusion criteria: a) Individuals with systemic diseases other than T2DM b) Obese individuals, BMI more than 25 kg/m2 c) Smokers d) Pregnant/Lactating and postmenopausal women e) Individuals who have received periodontal therapy in the last 6 months f) Individuals who have had a history of antimicrobial and anti-inflammatory therapy in last 6 months

Design outcomes

Primary

MeasureTime frame
Galectin-3 and TNF alpha levels in GCFTimepoint: 3 months

Secondary

MeasureTime frame
Clinical parameters - Gingival index, bleeding on probing, probing depth and clinical attachment lossTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Divya Shonima

The Oxford Dental College, Bangalore

24divyashonima@gmail.com9102403502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026